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Abstract  
Introduction Breast cancer is the leading killer of women in Malaysia. Nutritional status and 
adiponectin are modifiable risk factors for breast cancer occurrence which can be efficiently 
targeted. The purpose of this study was to determine the relationship between nutritional status 
and high molecular weight (HMW) adiponectin levels among breast cancer patients as compared 
to controls. 
Methods This was a case- control study, conducted in Hospital Universiti Sains Malaysia and 
Universiti Sains Malaysia campus. Newly diagnosed breast cancer cases (n=55) were assigned as 
cases while healthy controls (n=58) were staff members of HUSM and USM campus. 
Sociodemographic and reproductive data were obtained with a standard questionnaire while the 
dietary data was obtained from a validated diet history questionnaire. Anthropometric assessments 
[weight, height, hip, waist circumference (WC) and body fat composition] were measured while 
overnight fasting venous blood samples were analysed for lipid profiles, glucose, insulin, high 
sensitivity C-reactive protein and HMW adiponectin. 
Results A significant linear negative relationship exists between WC and HMW adiponectin (β=-
0.05; p=0.005) among breast cancer cases. Additionally, HDL cholesterol was positively associated 
with HMW adiponectin (β=1.83; p=0.010) among the cases. BMI was negatively associated with 
HMW adiponectin (β=-0.02; p=0.001) among healthy controls. 
Conclusion Our findings suggest that WC, BMI and HDL cholesterol had significant relationship with 
HMW adiponectin. Low levels of HMW adiponectin, low WC and high HDL levels may be protective 
against breast cancer. 
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Introduction 
Breast cancer is the most common cancer among 
Malaysian women, where its rates in Malaysia are 
higher than that reported in Southeast Asian 
countries. 1 One of the risk factos for breast cancer is 
obesity2 where the prevalence of overweight, 
obesity and abdominal obesity among Malaysian 
women have been reported to be 28.3%, 20.6% and 
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60.2%, respectively. In addition, the National Health 
and Morbidity Survey (NHMS) 2015 reported that 
there was an increasing trend in the adiposity 
prevalence among Malaysian women in 2015 
compared with 2011.3 
Nutritional status is an essential predictor of 
clinical outcome such as malnutrition. Impaired 
nutritional status have been linked with inadequate 
food intake, unsustained hunger and metabolic 
inefficiency.4 Several studies modulated nutritional 
status as the assessment of anthropometry and body 
composition such as body mass index and body fat 
distribution.5 In contrast, nutritional status also has 
been defined in the scope of dietary intake by 
considering food intakes and utilisation of nutrients 
were affecting the consumer‘s health condition.6 
Two main modifiable risk factors in 
prevention of cancer are body weight and dietary 
intake.7 However, the American Cancer Society 
provided new nutritional guidelines for prevention 
of cancer by grouping the recommendations into 
various categories of weight management, physical 
activity and dietary intake.8 This recommendation is 
useful as nutritional education in promoting good 
health and optimum nutritional status among public. 
Moreover, in an effort to increase patient’s quality 
of life, nutritional status is an important concern. For 
example, the Subjective Global Assessment (SGA) 
form has been utilized to screen patients with 
malnutrition in HUSM. This nutritional assessment 
tool may guide the incorporation of nutritional 
intervention in overcoming disease complications.9 
Previously, adipose tissue was thought to 
function only for storing fat for energy. However, 
recently it was recognized that adipose tissue is an 
endocrine organ that releases large amounts of 
biochemical modulators, including adipokines.10 
Among these adipokines, adiponectin which 
abundantly circulates in the plasma at high 
concentrations (0.5 to 30.0 μg/ml) and accounts for 
up to 0.01% of total plasma proteins11 are thought to 
play a major role in breast cancer development. 
Adiponectin exists in the plasma as trimer, hexamer 
or high molecular weight (HMW) adiponectin 
isoforms. Among these, the HMW isoform is the 
most biologically active form and is strongly 
associated with insulin resistance, metabolic 
syndrome, and cardiovascular disease.12 
Adiponectin is considered to be a protective 
hormone because it plays a major role in the 
regulation of glucose due to its potent insulin-
sensitizing activity which affect the uptake of 
glucose in the muscle. Furthermore, it is involved in 
lipid homeostasis, and in the pathophysiology of 
atherosclerosis due to its anti-inflammatory 
activity.13 Numerous studies have shown that 
adiponectin has an inhibitory effect on the 
proliferation of various cell types, including aortic 
smooth muscle, endothelial tissue and several types 
of cancer cells.14 It has been hypothesized that 
adiponectin act directly on breast cancer cells by 
inhibiting proliferation and angiogenesis or by 
stimulating apoptosis.15 Serum adiponectin is 
therefore a potential therapeutic target for breast 
cancer treatment or protection.16 
Although adiposity is a well-established 
health problem related to breast cancer, the data on 
the association between HMW adiponectin and 
adiposity obtained from various epidemiological 
studies has remained elusive in Asian countries, 
particularly Malaysia. Therefore, the aim of this 
study was to investigate the relationship between 
nutritional status and HMW adiponectin levels 
among breast cancer patients as compared to healthy 
controls. It is hoped that the data will provide 
essential information for health professionals 
planning public health programs for breast cancer 
prevention in Malaysia with respect to weight and 
reproductive health management.  
Methods 
 
Setting and subjects 
This is a case-control study conducted in Kelantan, 
Malaysia, approved by the Human Research and 
Ethical Committee of USM. The cases include 
newly diagnosed women with histologically 
confirmed malignant breast cancer (stages I to IV) 
who had not yet undergone any therapies (except for 
analgesics and/or surgery) while the controls 
comprised of healthy volunteers with no known 
history of breast cancer, any other medical illness or 
medication use. The inclusion criteria for both cases 
and controls were women aged 20 to 59 years old 
who were neither pregnant nor lactating during the 
study periods. Both cases and controls were 
recruited using a convenience sampling method 
while the controls were selected to match the cases 
for age ± 10 years.  
 
Measurements 
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Written informed consents were obtained and the 
respondents underwent face-to-face interviews 
using a set of questionnaires including validated diet 
history questionnaire (DHQ).17 The respondents 
were measured for height using a portable 
stadiometer, weight and fat composition using a 
body composition analyzer (TANITA SC-330, 
Japan), waist circumference (WC) and hip 
circumference using a non-extendible tape. BMI 
was calculated by dividing the weight (kg) by the 
square of the height (m). Fasting blood samples were 
collected for biochemical test. Serum HMW 
adiponectin concentrations were measured using a 
sandwich ELISA kit. 
Statistical analyses were performed using SPSS for 
Windows, version 22.0. Categorical data were 
presented as frequency (percentage), while chi-
squared or Fisher’s exact tests were used to 
determine the association between any categorical 
variables. Independent samples t-test was used to 
compare means and multiple linear regression 
analyses were used to investigate the associations 
between HMW adiponectin levels and nutritional 
status. A p value of less than 0.05 was considered as 
statistically significant. 
 
Results 
 
A total of 55 newly diagnosed breast cancer cases 
and 58 healthy controls were recruited (Table 1). 
The mean (SD) age for cases and controls were 
46.84 (7.87) years and 40.79 (9.78) years 
respectively. Education level of the cases mostly 
from primary or secondary school when compared 
to controls most of whom graduated from the 
university. The majority of the respondents were 
premenopausal women, practiced family planning, 
breastfed their babies, with no first degree family 
history of breast cancer. A higher percentage of 
cases (58.2%) were exposed to second-hand smoke 
as compared to controls (29.3%). 
Multiple linear regression analysis revealed 
that there was a significant linear negative 
relationship between WC and HMW adiponectin (p 
=0.005) where a 10 cm increase in WC lowers 
HMW adiponectin levels by 0.5 µg/ml (95% CI: -
0.8, -0.2 µg/ml) (Table 2). In addition, HDL 
cholesterol was positively associated with HMW 
adiponectin (p= 0.006). Furthermore, a 1 mmol/L 
increase in HDL cholesterol increases HMW 
adiponectin levels by 1.83 µg/ml (95% CI: 0.47, 
3.02 µg/ml). 
Table 3 shows the associations of nutritional 
status with HMW adiponectin among healthy 
controls. Multiple linear regression analysis 
revealed that there was a significant (p =0.001) 
linear negative relationship between BMI and HMW 
adiponectin where a 1 kg/m2 increase in BMI lowers 
HMW adiponectin levels by 0.20 µg/ml (95% CI: -
0.32, -0.08 µg/ml). 
 
Discussion 
Mean age at breast cancer diagnosis showed that 
mean age breast cancer cases were significantly 
older than healthy controls. This result is in a good 
agreement with the previous results reported by 
Fuhrman et al., who also had frequency matching 
case control by birth year in 5- year strata in United 
States.18 Age matched in this study was quite wide 
(±10 years) because of the difficulty faced in 
matching the older cases with older controls free 
from diseases as older women are synonym with the 
disease. However, one study from Vietnam found no 
significant difference in age between case and 
control groups matched on a single year of age.19 
According to a study conducted in Malaysia 
on breast cancer awareness, they concluded that 
education level emerged to contribute to health 
behavior and knowledge level, based on an outcome 
of women had higher education level were 
significantly more aware of breast cancer.20 In this 
present study, breast cancer cases mostly from 
primary and secondary school compared to healthy 
controls most of whom graduated from university. 
Poor education had accounted for late stage at 
presentation of breast cancer.21 A qualitative study 
was conducted by exploring the decision-making 
experiences of breast cancer women and discovered 
four phases in the decision-making process 
(discovery, confirmatory, deliberation and 
decision). Their knowledge, understanding and 
experiences affect the final decision for treatment.22 
Majority of the breast cancer cases were 
premenopausal women and this may be explained 
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through breast cancer is typically more aggressive in 
women under 40 years of age than in older women.23 
This is ordinarily applied to the fact that tumors in 
premenopausal women bear a higher percentage of 
biologically negative cellular or histological features 
which led to a worse prognosis.24 
In this study, exposure to secondhand smoke 
was significantly associated with breast cancer. This 
finding was consistent with recent study on non-
smoking breast cancer women with lifetime 
exposure to passive smoking. Exposure to second-
hand smoke had 1.27 (95% CI: 0.97, 1.66) (less than 
20 years) and 2.64 (95% CI: 1.87, 3.74) (more than 
20 years) times increase risk of breast cancer than 
unexposed women. Besides that, Caucasian women 
who experienced second-hand smoke both at work 
and home had 2.80 (95% CI: 1.84, 4.25) times 
higher risk of breast cancer compared with women 
who were never exposed to smoke.25  
To our knowledge, our study is the first to 
establish that WC and HDL cholesterol levels are 
associated with HMW adiponectin among breast 
cancer cases. In addition, BMI is also associated 
with HMW adiponectin among healthy controls. 
Our study successfully determined the association 
between nutritional status and HMW adiponectin 
among breast cancer cases and healthy controls. 
WC was negatively associated with HMW 
adiponectin among breast cancer cases which was 
consistent with another study among obese and non-
obese Caucasians indicating that WC is inversely 
correlated with HMW adiponectin level regardless 
Table 1 Baseline characteristics of the respondentsa 
Variables Cases 
(n=55) 
Controls 
(n=58) 
p valuec 
Age (years)b 46.84 (7.87) 40.79 (9.78) 0.001 
Education level    
 Primary/secondary                         
school 
35 (63.6) 21 (36.2) 0.004 
     University 20 (36.4) 37 (63.8)  
Exposure to second-hand smoke   
     Yes 32 (58.2) 17 (29.3) 0.002 
     No 23 (41.8) 41 (70.7)  
Monthly household income (RM)d,e   
     <RM 2,300 31 (57.4) 4 (7.3) <0.001 
    RM 2,300-5,599 13 (24.1) 34 (61.8) 0.403 
     >RM 5,600 10 (18.5) 17 (30.9)  
Family planning  
      Yes 28 (50.9) 37 (63.8) 0.167 
      No 27 (49.1) 21 (36.2)  
Age during first pregnancy,yearsb  25.75 (5.23) 25.34 (2.66) 0.631 
Parityb 3.61 (2.03) 3.25 (1.97) 0.335 
Breastfeeding    
    Yes 50 (90.9) 48 (82.8)  
     No 5 (9.1) 10 (17.2) 0.209 
Menopausal status    
     Premenopause  42 (76.4) 51 (87.9)  
     Postmenopause 13 (23.6) 7 (12.1) 0.113 
First degree family history with breast cancer   
     Yes  6 (10.9) 2 (3.4) 0.142 
     None  49 (89.1) 56 (96.6)  
Note. SD=Standard deviation; OR= Odds ratio; CI= Confidence interval 
    a Data are presented as frequency (percentage), unless otherwise indicated 
   b Data are presented as mean (SD) 
    c p value based on Independent t- test 
dBased on the cut-off of the 10th Malaysia Plan  
e Sample size was not n=113 due to missing values 
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with BMI levels26 indicating that obese individuals 
commonly have lower adiponectin levels based on 
their abdominal adiposity. On the contrary, higher 
levels of adiponectin were resorted in some obese 
individuals with higher subcutaneous adipose tissue-
to-visceral adipose tissue ratios where the ratios 
were significantly associated with adiponectin.27   
Table 2 Associations of nutritional status with HMW adiponectin among breast cancer cases 
Variables  Simple linear regression Multiple linear regression 
 ba (95% CI) p value Adjusted bb  
(95% CI) 
p value 
Weight (kg) -0.05 (-0.08,-0.02) 0.001   
Height (cm) -0.01 (-0.09,0.07) 0.870   
BMI (kg/m2) -0.13 (-0.21,-0.06) 0.001   
WC (cm) -0.07 (-0.10,-0.03) <0.001 -0.05 (-0.08,-0.02) 0.005 
HC (cm) -0.06 (-0.10,-0.02) 0.006   
Fat mass (kg) -0.06 (-0.10,-0.02) 0.007   
Muscle mass (kg) -0.16 (-0.26,-0.06) 0.003   
Visceral fat rating  -0.24 (-0.37,-0.10) 0.001   
TC (mmol/l) 0.22 (-0.22,0.65) 0.324   
HDL cholesterol (mmol/l) 2.60(1.24,3.97) <0.001 1.83 (0.47,3.20) 0.010 
LDL cholesterol (mmol/l) 0.16 (-0.35,0.66) 0.541   
TG (mmol/l) -0.30 (-0.67,0.07) 0.108   
Glucose (mmol/l) 0.02 (-0.15,0.19) 0.800   
hs-CRP (mg/ml) -0.07 (-0.14,0.01) 0.088   
Insulin (μU/ml) -0.038 (-0.080,-0.004) 0.074   
Energy (kcal/day) -0.001 (-0.002,0.001) 0.272   
Protein (g/day) -0.007 (-0.036.0.021) 0.608   
Carbohydrate (g/day) -0.006 (-0.016,0.003) 0.193   
Fat (g/day) -0.015 (-0.054,0.024) 0.433   
Saturated fat (g/day) 0.032 (-0.122,0.185) 0.678   
MUFA (g/day) -0.052 (-0.205,0.102) 0.501   
PUFA (g/day) -0.107 (-0.251,0.037) 0.140   
Calcium (mg/day) 0.000 (-0.002,0.003) 0.928   
Phosphorus (mg/day) -0.001 (-0.002,0.001) 0.274   
Iron (mg/day) -0.070 (-0.155,0.015) 0.105   
Cholesterol (mg/day) -0.004 (-0.012,0.003) 0.228   
Thiamin (mg/day) 0.020 (-2.251,2.291) 0.986   
Riboflavin (mg/day) 0.225 (-0.992,1.442) 0.711   
Niacin (mg NE/day) -0.062 (-0.264,0.139) 0.536   
Folate (µg/day) -0.002 (-0.013,0.009) 0.695   
Vitamin C (mg/day) 0.002 (-0.003,0.007) 0.511   
Vitamin E (mg/day) -0.047 (-0.237,0.144) 0.624   
Selenium (µg/day) -0.010 (-0.042,0.021) 0.517   
Fiber (g/day) -0.087 (-0.369,0.194) 0.534   
Sugar (g/day) 0.003 (-0.025,0.030) 0.857   
Note. BMI=body mass index, WC= Waist circumference; HC=hip circumference; TC=total Cholesterol; HDL=high density 
lipoprotein cholesterol; LDL=low density lipoprotein cholesterol; TG=triglyceride; hs-CRP=high sensitivity C reactive 
protein; MUFA=monounsaturated fatty acid; PUFA=polyunsaturated fatty acid 
aCrude regression coefficient 
bAdjusted regression coefficient  
Stepwise multiple linear regression method applied. Model assumptions were fulfilled.  
Interactions amongst independent variables and multicollinearity were not applicable.  
Coefficient of determination (R2) = 0.377 
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Obesity is recognized as risk factor for breast cancer 
among both post- and pre-menopausal women.28 
Excess adipose tissue significantly increases the risk 
of breast cancer by 30-50%.29 Understanding the 
role of obesity in carcinogenesis is of major 
importance, especially for obese women with breast 
Table 3 Associations of nutritional status with HMW adiponectin among healthy controls 
Variables  Simple linear regression Multiple linear regression 
 ba (95% CI) p value Adjusted bb 
 (95% CI) 
p value 
Weight,kg -0.08 (-0.13,-0.03) 0.001   
Height,cm -0.09 (-0.01,-0.19) 0.083   
BMI,kg/m2 -0.20 (-0.32,-0.08) 0.001 -0.20 (-0.32,-0.08) 0.001 
WC,cm -0.08 (-0.13,-0.03) 0.001   
HC,cm -0.07 (-0.13,-0,01) 0.018   
Fat mass,kg -0.11 (-0.19,-0.04) 0.002   
Muscle mass,kg -0.08 (-0.26,0.10) 0.405   
Visceral fat rating  -0.15 (-0.29,-0.01) 0.035   
TC (mmol/l) -0.22 (-0.78,0.33) 0.420   
HDL cholesterol (mmol/l) 2.18 (0.26,4.09) 0.027   
LDL cholesterol (mmol/l) -0.30 (-0.92,0.32) 0.339   
TG (mmol/l) -1.05 (-2.03,-0.08) 0.035   
Glucose (mmol/l) -0.10 (-0.44,0.25) 0.565   
hs-CRPa (mg/ml) -0.04 (-0.08,0.01) 0.110   
Insulina (μU/ml) -0.02 (-0.07,0.03) 0.459   
Energy (kcal/day) -0.001 (-0.003,0.002) 0.545   
Protein (g/day) -0.017 (-0.060,0.027) 0.452   
Carbohydrate (g/day) -0.007 (-0.020,0.005) 0.255   
Fat (g/day) -0.011 (-0.061,0.039) 0.665   
Saturated fat (g/day) 0.008 (-0.184,0.199) 0.937   
MUFA (g/day) -0.032 (-0.163,0.100) 0.632   
PUFA (g/day) -0.051 (-0.208,0.106) 0.518   
Calcium (mg/day) 0.001 (-0.003,0.005) 0.606   
Phosphorus (mg/day) -0.001 (-0.003,0.001) 0.446   
Iron (mg/day) -0.003 (-0.105,0.098) 0.946   
Cholesterol (mg/day)  -0.001 (-0.012,0.010) 0.858   
Thiamin (mg/day) 0.986 (-1.680,3.651) 0.462   
Riboflavin (mg/day) 2.114 (0.144,4.083) 0.036   
Niacin (mg NE/day) 0.009 (-0.150,0.168) 0.913   
Folate (µg/day) 0.001 (-0.013,0.015) 0.887   
Vitamin A (µg/day) 0.001 (-0.001,0.003) 0.441   
Vitamin C (mg/day) 0.006 (-0.006,0.018) 0.341   
Vitamin E (mg/day) -0.007 (-0.362,0.347) 0.968   
Selenium (µg/day) -0.018 (-0.066,0.031) 0.466   
Dietary fiber (g/day) 0.013 (-0.386,0.411) 0.949   
Sugar (g/day) 0.033 (-0.005,0.070) 0.084   
Note. BMI=body mass index, WC= Waist circumference; HC=hip circumference; TC=total Cholesterol; HDL=high density 
lipoprotein cholesterol; LDL=low density lipoprotein cholesterol; TG=triglyceride; hs-CRP=high sensitivity C reactive 
protein; MUFA=monounsaturated fatty acid; PUFA=polyunsaturated fatty acid 
aCrude regression coefficient 
bAdjusted regression coefficient  
Stepwise multiple linear regression method applied. Model assumptions were fulfilled.  
Interactions amongst independent variables and multicollinearity were not applicable.  
Coefficient of determination (R2) = 0.168 
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cancer. Recently, it has been proposed that the 
association between cancer development and 
adiposity is related to (1) sex hormone metabolism, 
(2) insulin and insulin-like growth factor (IGF) 
signaling and (3) the physiology and pathological 
processes of adipokines.30  
Our study also indicated that BMI was 
negatively associated with HMW adiponectin level 
among healthy controls. Similarly, Nakanishi and 
colleagues (2016) also who concluded that BMI was 
significantly lower in increased adiponectin among 
healthy men.31 In contrast, a cohort study among 
healthy males and females showed no significant 
association in women between BMI and adiponectin 
but interestingly, positive association of BMI with 
adiponectin in males possibly is due to significantly 
higher levels of adiponectin levels in men as 
compared to that in women.32 Decreased plasma 
testosterone in obese male33 may also explain the 
higher levels of adiponectin in man since 
testosterone has been reported to selectively 
decrease circulating levels of HMW adiponectin by 
inhibiting its secretion from the adipocytes.34 
A similar outcome was also be reported in a 
disease-related group where negative correlation 
between BMI and adiponectin has been established 
among breast cancer patients.35 Moreover, patients 
with chronic obstructive pulmonary disease had 
remarkably higher adiponectin levels which are 
inversely correlated with BMI.36 The elevation in 
adiponectin level may be associated with body 
weight loss among these patients.37  In fact, 
adiponectin levels was inversely correlated with 
BMI and was downregulated with obesity.38 This is 
supported by a dietary and exercise intervention 
study which indicated that weight loss was inversely 
associated with adiponectin concentrations.39 
However, BMI and adiponectin were positively 
correlated in patients with multiple sclerosis though 
the correlation was not significant.40 
This study demonstrated that HDL 
cholesterol was significantly associated with HMW 
adiponectin. The current result support the previous 
study showing significant positive correlation 
between adiponectin levels and HDL cholesterol.41 
HDL cholesterol had been proposed to have cardio-
protective effect42 and it is possible that the form of 
HMW adiponectin may carry a lipid-soluble 
factor.43 According to Rothenbacher (2005), high 
serum concentration may acted as protective effect 
when mediated by the effects of lipoprotein 
metabolism remarkably HDL cholesterol. This was 
concluded based on a study among patients with 
coronary heart disease presented strong correlation 
between adiponectin and HDL cholesterol.44 
However, no significant direct effect of HDL 
cholesterol on adiponectin among type 2 diabetes 
cases except this relationship was intervened with 
pre-heparin lipoprotein lipase, a major enzyme in 
lipoprotein metabolism.45 
Recent epidemiological study have shown a 
strong relationship between breast cancer and lipid 
disorders, including HDL cholesterol.46 Declined 
HDL cholesterol contributed to elevated breast 
cancer risk.47 A case-control study conducted to 
determine the correlation of adiponectin with risk 
factors of breast cancer among premenopause and 
post menopause women found that HDL cholesterol 
levels were significantly lower in controls than cases 
as well as positive correlation between adiponectin 
and HDL cholesterol.48 
In conclusion, this study suggests that there 
is an association between nutritional status and 
HMW adiponectin. WC, BMI and HDL cholesterol 
had significant relationship with HMW adiponectin. 
Breast cancer in Malaysia could be prevented 
through nutritional education via public health 
programs. 
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